Researchers Nanoprint Electrodes for Customized Treatments of Disease

Researchers Nanoprint Electrodes for Customized Treatments of Disease


Publication/Creation Date
October 5 2022
Creators/Contributors
Carnegie Mellon University (creator)
Rahul Panat (contributor)
Eric Yttri (contributor)
Media Type
Press Release
Persuasive Intent
Academic
Discursive Type
Inventions
Description
"Carnegie Mellon University researchers have pioneered the CMU Array — a new type of microelectrode array for brain computer interface platforms. It holds the potential to transform how doctors are able to treat neurological disorders.

3D printed at the nanoscale, the ultra-high-density microelectrode array (MEA) is fully customizable. This means that one day, patients suffering from epilepsy or limb function loss due to stroke could have personalized medical treatment optimized for their individual needs."

Researchers say that it may take 5 years before human testing and even longer before any kind of commercialization. A patent is also in process. 

HCI Platform
Implantables
Relation to Body
In
Related Body Part
Brain
Marketing Keywords
CMU Array, Utah Array, Michigan Array
Source
https://www.cmu.edu/mcs/news-events/2022/1005_brain-arrays.html

Date archived
November 1 2022
Last edited
November 1 2022
How to cite this entry
Carnegie Mellon University. (October 5 2022). "Researchers Nanoprint Electrodes for Customized Treatments of Disease". Mellon College of Science News. Fabric of Digital Life. https://fabricofdigitallife.com/Detail/objects/5874